The first week of February 2026 will be remembered as the day the pharmaceutical sector’s most famous partnership officially ...

Novo Nordisk is fighting back with CagriSema, a powerful combination therapy that demonstrated 22.7% weight loss in its own Phase 3 trials. While this result is superior to the current market leader, ...